Idexx Laboratories Remainder of Fiscal Year 2024 increased by 296.8% to $23.63M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.4%, from $21.41M to $23.63M.
remainder_2024| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.95M | $4.59M | $17.07M | $10.68M | $4.47M | $17.09M | $11.16M | $4.93M | $17.63M | $11.58M | $4.63M | $21.41M | $14.49M | $5.96M | $23.63M |
| QoQ Change | — | -53.9% | +272.3% | -37.4% | -58.1% | +282.2% | -34.7% | -55.8% | +257.5% | -34.3% | -60.0% | +362.6% | -32.3% | -58.9% | +296.8% |
| YoY Change | — | — | — | +7.4% | -2.5% | +0.1% | +4.5% | +10.2% | +3.1% | +3.8% | -6.1% | +21.5% | +25.1% | +28.7% | +10.4% |